MeganNakashimaMD

Pathology • Cleveland, OH

Hematopathology, Anatomic Pathology, Clinical Pathology

Physician

Join to view full profile

Dr. Nakashima is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nakashima's full profile

Already have an account?

Office
9500 Euclid Ave
# L-25
Cleveland, OH 44195
Phone+1 216-444-1860

Education & Training

Cleveland Clinic FoundationFellowship, Hematopathology, 2012 - 2013
Washington University/B-JH/SLCH ConsortiumFellowship, Selective Pathology, 2011 - 2012
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2007 - 2011
Washington University in St. Louis School of MedicineClass of 2007

Certifications & Licensure

OH State Medical License 2012 - 2026
PA State Medical License 2007 - 2021
MO State Medical License 2011 - 2012
American Board of Pathology Pathology - Anatomic/Pathology - Clinical
American Board of Pathology Hematopathology

Publications & Presentations

PubMed

2 citations
IgM monoclonal gammopathy of undetermined significance: clinicopathologic features with and without IgM-related disorders.
Frido K Bruehl, Peter Mannion, Elisha Barbato, Megan O Nakashima, James R Cook
Haematologica. 2023-10-01
54 citations
Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features.
Valeria Visconte, Megan O. Nakashima, Heesun J. Rogers
Cancers. 2019-11-22
13 citations
Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
Katalin Kelemen, Leonie Saft, Fiona E. Craig, Attilio Orazi, Megan O. Nakashima
American Journal of Clinical Pathology. 2021-02-04

Abstracts/Posters

Depth of Pre-Treatment Immunoparesis Is an Important Prognostic Factor for Survival in Relapsed Multiple Myeloma
Megan Nakashima, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Authored Content

A Day in the Life: Blood, Sweat, and SmearsSeptember 2020

Press Mentions

In Hematopathology, Online Learning Mirrors PracticeJuly 23rd, 2024
Urinalysis: ‘A Field with the Potential to Do More’: Pathologist, Two Companies Talk About Urinalysis Now and What’s NeededDecember 17th, 2020
Panel Explores Urinalysis Solutions, Rules, POC TestingDecember 1st, 2019